Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 329 | 598 | N/A | 1,197 | 0 |
| TOTAL | $760 | $1,033 | $N/A | $2,005 | $0 |
| Non-Current Assets | |||||
| Investments And Advances | 230,184 | 230,024 | 0 | 230,000 | 0 |
| Other Non-Current Assets | 77 | 179 | 0 | 0 | 0 |
| TOTAL | $230,261 | $230,203 | $N/A | $230,000 | $N/A |
| Total Assets | $231,020 | $231,235 | $N/A | $232,005 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28 | 42 | 0 | 0 | 0 |
| Accrued Expenses | 346 | 345 | N/A | 48 | 0 |
| TOTAL | $374 | $387 | $N/A | $48 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 239,889 | 244,092 | 0 | 250,933 | 0 |
| TOTAL | $239,889 | $244,092 | $N/A | $250,933 | $N/A |
| Total Liabilities | $240,262 | $244,478 | $N/A | $250,981 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 239 | 239 | 239 | 239 | N/A |
| Common Shares | 1 | 1 | N/A | 1 | 0 |
| Retained earnings | -9,243 | -13,244 | N/A | -18,976 | 0 |
| TOTAL | $-9,242 | $-13,243 | $N/A | $-18,975 | $0 |
| Total Liabilities And Equity | $231,020 | $231,235 | $0 | $232,005 | $0 |